Dash Bio, the company building the infrastructure that drug development needs for the next generation of medicines, today announced it has raised $30 million in Series A financing. The round was led ...
AMEC semiconductor equipment earnings reveal China's plasma etching sector has crossed into verified operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results